Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Cost effectiveness of pegylated interferon alpha 2b and ribavirin combination in chronic hepatitis C.

× No keyword cloud information.

3 in total

1. Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study.

Authors: F Imbert-Bismut; V Ratziu; L Pieroni; F Charlotte; Y Benhamou; T Poynard
Journal: Lancet Date: 2001-04-07 Impact factor: 79.321

2. Pretreatment evaluation of chronic hepatitis C: risks, benefits, and costs.

Authors: J B Wong; W G Bennett; R S Koff; S G Pauker
Journal: JAMA Date: 1998 Dec 23-30 Impact factor: 56.272

3. A prospective assessment of the inter-laboratory variability of biochemical markers of fibrosis (FibroTest) and activity (ActiTest) in patients with chronic liver disease.

Authors: Philippe Halfon; Françoise Imbert-Bismut; Djamila Messous; Gilles Antoniotti; Didier Benchetrit; Philippe Cart-Lamy; Gilles Delaporte; Danièle Doutheau; Théo Klump; Michel Sala; Didier Thibaud; Elisabeth Trepo; Dominique Thabut; Robert P Myers; Thierry Poynard
Journal: Comp Hepatol Date: 2002-12-30

3 in total

2 in total

1. Peginterferon {alpha}-2b and ribavirin therapy in chronic hepatitis C genotype 4: impact of treatment duration and viral kinetics on sustained virological response.

Authors: S M Kamal; A A El Tawil; T Nakano; Q He; J Rasenack; S A Hakam; W A Saleh; A Ismail; A A Aziz; M Ali Madwar
Journal: Gut Date: 2005-06 Impact factor: 23.059

2. Overview of the diagnostic value of biochemical markers of liver fibrosis (FibroTest, HCV FibroSure) and necrosis (ActiTest) in patients with chronic hepatitis C.

Authors: Thierry Poynard; Françoise Imbert-Bismut; Mona Munteanu; Djamila Messous; Robert P Myers; Dominique Thabut; Vlad Ratziu; Anne Mercadier; Yves Benhamou; Bernard Hainque
Journal: Comp Hepatol Date: 2004-09-23

2 in total